OrbiMed Israel GP Ltd.
CIK 1569590 · last filed 2026-04-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.57M
Companies
6
Total Filings
17
Lifetime Open-Market Net
-$47.47M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ACET | Director | 78,499 | $8.20 | $643.7K | -$5.40M | 2 | 2026-04-09 |
| BiomX Inc. (PHGE.WS) Delisted | Director | 2,813,489 | $0.01 | $24.8K | $242.5K | 3 | 2021-07-30 |
| 9 METERS BIOPHARMA, INC. (NMTR) Delisted | Director | 1,597 | $0.07 | $115 | -$41.87M | 6 | 2021-06-25 |
| CMMB | 10%+ Owner | 644,544 | $1.43 | $921.7K | $0 | 1 | 2021-03-18 |
| Eledon Pharmaceuticals, Inc. (NVUS) Delisted | Director | 73,650 | — | — | -$451.8K | 2 | 2020-12-04 |
| Eledon Pharmaceuticals, Inc. (TKAI) Delisted | Director | 2,537,110 | — | — | $0 | 1 | 2017-05-11 |
Recent Filings · Page 2 of 2
17 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-09-17 | ACET | Grant (A) | +42,129,164 | $0 | EDGAR |
| 2020-07-02 | 9 METERS BIOPHARMA, INC. (NMTR) Delisted | Conv (C) | +13,573,000 | $0 | EDGAR |
| 2020-05-05 | 9 METERS BIOPHARMA, INC. (NMTR) Delisted | Buy (P) | — | $0 | EDGAR |
| 2019-12-20 | BiomX Inc. (PHGE.WS) Delisted | Buy (P) | +8,000 | $71.2K | EDGAR |
| 2019-12-09 | BiomX Inc. (PHGE.WS) Delisted | Buy (P) | +20,400 | $171.3K | EDGAR |
| 2019-05-06 | Eledon Pharmaceuticals, Inc. (NVUS) Delisted | Buy (P) | +1,292,408 | $4.01M | EDGAR |
| 2017-05-11 | Eledon Pharmaceuticals, Inc. (TKAI) Delisted | Grant (A) | +5,074,220 | $0 | EDGAR |
Showing 11–17 of 17
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.